MYC and inflammatory breast carcinoma: We performed a meta-analysis of published data12,52–56 and demonstrate that the frequency of MYC genomic alterations in primary IBC is 23% (95% CI: 13–33%) vs. 30% (95% CI: 24–37%) in a subtype matched nIBC series consisting of METABRIC and TCGA samples respectively.